Cannabis Law Report

MARCH 13, 2019

Kays has been named an Illinois Super Lawyers® Rising Star each year since 2010. She teaches trial advocacy for the Notre Dame Law School and has coached trial team for Chicago-Kent Law School. plaintiff smoked medical marijuana for an alleged non-work related condition prior to going to sleep. During law school, Ms.

Marijuana 45

Marijuana Policy Advocacy State Laws 45

Cannabis Law Report

JULY 25, 2022

“There’s everything from people being dosed without their consent, to people being encouraged to sleep with practitioners in exchange for services, to people being pressured to participate in group contexts, and so-called rituals that they otherwise wouldn’t have engaged in.” ” Underground researcher.

Medicine 52

Medicine Therapy Research and Development Business 52

SMPL

MAY 26, 2020

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. In June of 2010, the host of the 2011 summit, the biochemist Ms.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

SEPTEMBER 23, 2019

27 There is moderate evidence for the use of cannabinoids for sleep and limited evidence for use in psychiatric conditions, such as post-traumatic stress disorder, depression, anxiety, and psychosis; appetite stimulation and weight gain; and no evidence for cancer treatment. Moderate evidence exists for the use of cannabis for sleep.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 24, 2021

However, from 2010, a dramatic increase is observable in articles about medicinal cannabis in the publications under analysis. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. The number of articles across the longitudinal period can be viewed in Fig. Conditions most frequently mentioned.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Healing Advocacy Fund.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51